January 16, 2020

Scottish Project Tackles Environmental Impact Of Pharmaceutical Drugs

NEWS A new Scottish health project aims to tackle the harm caused to the environment by pharmaceutical drugs. COMMENT It has been clear for years now […]
December 19, 2019

Contaminants From Prescription-Drug Factories Polluting Waterways

NEWS Typically, wastewater treatment plants are not equipped to remove pharmaceuticals. When scientists from the United States Geological Survey tested effluent from the Morgantown, West Virginia, […]
December 12, 2019

New Report Concludes Pharma Industry Is Distorting Medical Research And Education

NEWS A new report from the Organization for Economic Co-operation and Development (OECD) has concluded that widespread pharma industry influence is jeopardizing the integrity of medical research […]
December 5, 2019

Study Confirms Price-Gouging Is Central To Drug Industry’s Business Model

NEWS The pharma industry’s quest for profits is what is driving up drug prices, confirms Dennis Bourdette, M.D., chair of neurology in the Oregon Health and […]
December 5, 2019

United States Federal Prosecutors Launch Criminal Investigation Into Opioid Drug Makers

NEWS Employing laws normally used to go after illicit drug dealers, United States federal prosecutors have opened a criminal investigation into whether pharmaceutical companies intentionally allowed […]
November 27, 2019

Statin Drugs Increase Risk Of Diabetes And Skin Infections

A new study has found that using cholesterol-lowering statin drugs for even as little as three months can put patients at risk of developing diabetes, as well as skin and soft tissue infections.
November 19, 2019

U.S. Supreme Court Rejects Former Pharma CEO’s Appeal Against Seven-Year Prison Sentence

The U.S. Supreme Court has denied Martin Shkreli's appeal request over his 2017 fraud conviction, effectively upholding his seven-year prison sentence.
November 14, 2019

Big Drugmakers Could Lose $1 Trillion In Sales And Still Be Most Profitable Industry

A new analysis of publicly reported financial data has found that large, brand-name drug manufacturers would still be the most profitable industry sector in the United States even with $1 trillion in lower sales.